SGMO - Sangamo Therapeutics Inc
IEX Last Trade
0.8473
0.022 2.620%
Share volume: 1,854,331
Last Updated: Fri 30 Aug 2024 09:59:26 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.83
0.02
2.69%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-23 | 2023-05-08 | 2023-08-08 | 2023-11-01 | 2024-03-13 | 2024-05-09 | |
| Total revenue | 29.378 M | 26.460 M | 27.230 M | 157.957 M | 6.835 M | 9.398 M | 2.042 M | 481.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 29.378 M | 26.460 M | 27.230 M | 157.957 M | 6.835 M | 9.398 M | 2.042 M | 481.000 K | |
| -9.93% | 2.91% | 480.08% | -95.67% | 37.50% | -78.27% | -76.44% | |||
| Operating expenses | 75.112 M | 81.354 M | 82.622 M | 81.352 M | 79.060 M | 71.007 M | 63.805 M | 47.658 M | |
| Selling general and admin | 15.093 M | 16.238 M | 16.443 M | 18.136 M | 16.014 M | 13.918 M | 13.099 M | 11.767 M | |
| Research and development | 60.019 M | 65.116 M | 66.179 M | 63.216 M | 63.046 M | 57.089 M | 50.706 M | 35.891 M | |
| Total expenses | 75.112 M | 81.354 M | 82.622 M | 81.352 M | 79.060 M | 71.007 M | 63.805 M | 47.658 M | |
| 8.31% | 1.56% | -1.54% | -2.82% | -10.19% | -10.14% | -25.31% | |||
| Operating income | -45.734 M | -54.894 M | -55.392 M | 76.605 M | -72.225 M | -61.609 M | -61.763 M | -47.177 M | |
| Ebit | -45.734 M | -54.894 M | -55.392 M | 76.605 M | -72.225 M | -61.609 M | -61.763 M | -47.177 M | |
| Pretax income | -43.091 M | -53.125 M | -51.714 M | 21.327 M | -120.770 M | -102.893 M | -60.567 M | -48.991 M | |
| 23.29% | -2.66% | -141.24% | -666.28% | -14.80% | -41.14% | -19.11% | |||
| Income tax | 82.000 K | 30.000 K | 259.000 K | 194.000 K | -6.264 M | 1.270 M | -272.000 K | 98.000 K | |
| Net income basic | -43.173 M | -53.155 M | -51.973 M | 21.133 M | -114.506 M | -104.163 M | -60.295 M | -49.089 M | |
| -23.12% | 2.22% | 140.66% | -641.84% | 9.03% | 42.11% | 18.59% | |||
| Net income | -43.173 M | -53.155 M | -51.973 M | 21.133 M | -114.506 M | -104.163 M | -60.295 M | -49.089 M | |
| -23.12% | 2.22% | 140.66% | -641.84% | 9.03% | 42.11% | 18.59% |